DK63085A - Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre - Google Patents

Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre Download PDF

Info

Publication number
DK63085A
DK63085A DK63085A DK63085A DK63085A DK 63085 A DK63085 A DK 63085A DK 63085 A DK63085 A DK 63085A DK 63085 A DK63085 A DK 63085A DK 63085 A DK63085 A DK 63085A
Authority
DK
Denmark
Prior art keywords
dihydro
pyridine
dimethyl
dicarboxylic acid
asymmetric diesters
Prior art date
Application number
DK63085A
Other languages
English (en)
Other versions
DK160985B (da
DK63085D0 (da
DK160985C (da
Inventor
Dante Nardi
Amedeo Leonardi
Gabriele Graziani
Giorgio Bianchi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10556581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK63085(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of DK63085D0 publication Critical patent/DK63085D0/da
Publication of DK63085A publication Critical patent/DK63085A/da
Publication of DK160985B publication Critical patent/DK160985B/da
Application granted granted Critical
Publication of DK160985C publication Critical patent/DK160985C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
DK063085A 1984-02-14 1985-02-12 Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse DK160985C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8403866 1984-02-14
GB848403866A GB8403866D0 (en) 1984-02-14 1984-02-14 Diphenylalkylaminoalkyl esters

Publications (4)

Publication Number Publication Date
DK63085D0 DK63085D0 (da) 1985-02-12
DK63085A true DK63085A (da) 1985-08-15
DK160985B DK160985B (da) 1991-05-13
DK160985C DK160985C (da) 1991-11-04

Family

ID=10556581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK063085A DK160985C (da) 1984-02-14 1985-02-12 Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse

Country Status (29)

Country Link
US (3) US4705797A (da)
EP (1) EP0153016B1 (da)
JP (1) JPS60199874A (da)
KR (1) KR910005231B1 (da)
AR (1) AR240804A1 (da)
AT (1) ATE52772T1 (da)
AU (1) AU570534B2 (da)
BR (1) BR1101167A (da)
CA (1) CA1277666C (da)
DE (2) DE10199007I2 (da)
DK (1) DK160985C (da)
DZ (1) DZ748A1 (da)
EG (1) EG17772A (da)
ES (1) ES540385A0 (da)
FI (1) FI83954C (da)
GB (1) GB8403866D0 (da)
GR (1) GR850363B (da)
HU (1) HU194171B (da)
IE (1) IE57715B1 (da)
IL (1) IL74238A (da)
LU (1) LU90069I2 (da)
MX (1) MX156874A (da)
NL (1) NL970025I2 (da)
NO (2) NO166123C (da)
NZ (1) NZ210866A (da)
PH (1) PH20725A (da)
PT (1) PT79963B (da)
SG (1) SG48590G (da)
ZA (1) ZA85656B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
DE3677319D1 (de) * 1985-10-22 1991-03-07 Sanwa Kagaku Kenkyusho Co Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
JPH02149563A (ja) * 1988-11-30 1990-06-08 Nisshin Flour Milling Co Ltd ２−ハロエトキシカルボニル基を含有する１，４−ジヒドロピリジン誘導体の製造法
IT1274480B (it) * 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
IT1279529B1 (it) * 1995-05-12 1997-12-16 Recordati Chem Pharm Procedimento di preparazione ed uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
US5851636A (en) * 1995-12-29 1998-12-22 Lantec Products, Inc. Ceramic packing with channels for thermal and catalytic beds
ITMI20011727A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20050101640A1 (en) * 2002-10-16 2005-05-12 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
CA2753318A1 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
WO2005107374A2 (en) * 2004-05-07 2005-11-17 Sun Pharmaceutical Industries Limited A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative
EP1796653A2 (en) * 2004-07-26 2007-06-20 Actelion Pharmaceuticals Ltd. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
US20060134212A1 (en) * 2004-09-02 2006-06-22 Forest Laboratories, Inc. Lercanidipine immediate release compositions
US20060165789A1 (en) * 2004-09-09 2006-07-27 Forest Laboratories, Inc. Lercanidipine modified release compositions
US20060165788A1 (en) * 2004-09-09 2006-07-27 Wattanaporn Abramowitz Lercanidipine pH dependent pulsatile release compositions
KR100616276B1 (ko) * 2004-09-21 2006-08-28 일동제약주식회사 2,엔-디메틸-엔-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
KR100651212B1 (ko) 2004-10-27 2006-12-01 제일약품주식회사 무정형 레르카니디핀의 제조방법
IL165525A0 (en) * 2004-12-02 2006-01-15 Motivan Ltd Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
KR100638171B1 (ko) * 2005-03-25 2006-10-26 건일제약 주식회사 2,ｎ-디메틸-ｎ-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법
ATE445602T1 (de) 2005-06-15 2009-10-15 Hetero Drugs Ltd Neues verfahren zur herstellung von lercanidipin
WO2007031865A2 (en) 2005-09-16 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
EP1963254A2 (en) * 2005-09-21 2008-09-03 Torrent Pharmaceuticals Ltd Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) * 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2007120135A1 (en) * 2006-04-17 2007-10-25 Forest Laboratories, Inc. Lercanidipine immediate release composition
DE602006003877D1 (de) * 2006-05-24 2009-01-08 Cf Pharma Ltd Verfahren zur Herstellung von Lercanipidin
PT2046745E (pt) * 2006-08-04 2014-01-15 Recordati Ireland Ltd Processo para preparação de cloridrato de lercanidipina amorfo
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2114883A4 (en) * 2006-12-29 2010-09-08 Dongwoo Syntech Co Ltd PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
KR100848935B1 (ko) 2007-05-16 2008-07-29 주식회사 대희화학 생체 촉매 효소를 이용한 광학 선택적 가수분해방법
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino
WO2012123966A1 (en) 2011-03-04 2012-09-20 Arch Pharmalabs Limited Process for the preparation of 4 -substituted -1, 4-dihydropyridines
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
JPS5762257A (en) * 1980-10-03 1982-04-15 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503424D0 (en) * 1985-02-11 1985-03-13 Ici Plc Heterocyclic derivatives

Also Published As

Publication number Publication date
PT79963B (en) 1986-11-10
FI83954C (fi) 1991-09-25
DK160985B (da) 1991-05-13
JPH0517908B2 (da) 1993-03-10
NO166123B (no) 1991-02-25
KR910005231B1 (ko) 1991-07-24
NO166123C (no) 1991-06-05
DE3577703D1 (de) 1990-06-21
IE57715B1 (en) 1993-03-10
DE10199007I1 (de) 2001-04-12
PT79963A (en) 1985-03-01
EP0153016B1 (en) 1990-05-16
NL970025I2 (nl) 1998-01-05
AU3868985A (en) 1985-09-12
AR240804A2 (es) 1991-02-28
NO850521L (no) 1985-08-15
EP0153016A2 (en) 1985-08-28
CA1277666C (en) 1990-12-11
DZ748A1 (fr) 2004-09-13
GB8403866D0 (en) 1984-03-21
JPS60199874A (ja) 1985-10-09
DK63085D0 (da) 1985-02-12
HU194171B (en) 1988-01-28
GR850363B (da) 1986-02-06
MX156874A (es) 1988-10-08
EP0153016A3 (en) 1985-10-02
PH20725A (en) 1987-03-30
NL970025I1 (nl) 1997-09-01
US4968832A (en) 1990-11-06
DE10199007I2 (de) 2003-01-09
DK160985C (da) 1991-11-04
US4772621A (en) 1988-09-20
FI850535L (fi) 1985-08-15
IE850280L (en) 1985-08-14
LU90069I2 (fr) 1997-07-23
NO2000011I1 (no) 2000-10-17
ES8602664A1 (es) 1985-11-16
HUT37399A (en) 1985-12-28
BR1101167A (pt) 2004-08-17
US4705797A (en) 1987-11-10
ATE52772T1 (de) 1990-06-15
EG17772A (en) 1991-08-30
NZ210866A (en) 1988-07-28
FI850535A0 (fi) 1985-02-08
ZA85656B (en) 1985-08-28
ES540385A0 (es) 1985-11-16
IL74238A (en) 1988-07-31
SG48590G (en) 1990-08-17
AR240804A1 (es) 1991-02-28
KR850005826A (ko) 1985-09-26
FI83954B (fi) 1991-06-14
AU570534B2 (en) 1988-03-17
IL74238A0 (en) 1985-05-31

Similar Documents

Publication Publication Date Title
DK63085D0 (da) Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre
DK224086D0 (da) Fremstilling af (threo)-1-aryl-2-acylamido-3-flour-1-propanoler
DK207286D0 (da) Regulering af blodstroemning
DK301885A (da) Sulfinylforbindelser
DK52886D0 (da) Karboxylsyreesterderivater af deglucoteicoplanin
DK38593A (da) Alkoxymethylethere af glyceroler
ES546487A0 (es) 1,4-dihidropiridinas
DK436685D0 (da) Fremgangsmaade til fremstilling af 2,4-dichlor-5-fluor-benzoesyre
DK162997C (da) Fremgangsmaade til fremstilling af 5,6,7,8-tetrahydrofolinsyre
DK165686D0 (da) 1,4-dihydropyridin-3,5-dicarboxylatderivater
DE3585702D1 (de) Herstellung von (trifluormethyl)pyridinen.
DK220885A (da) Lactoner
DK234485A (da) Substituerede phenoxyphenylpropionsyrederivater
DK175587D0 (da) Fremstilling af substituerede (dichlormethyl)-pyridiner
DK288085D0 (da) Dihydropyridinderivater
DK569185A (da) 1,4-dihydropyridinderivater
DK160819C (da) Fremgangsmaade til fremstilling af 3,5-dichlor-2-pyridon
DK343981A (da) Fremstilling af 3,5-dimethyl-4-pentensyre
DK226685A (da) Estere af 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl eller alkoxyalkoxycarbonyl)-4-(substitueret phenyl)-pyridin-5-carboxylsyre
SE8406185D0 (sv) Novel n-substituted dihydropyridines

Legal Events

Date Code Title Description
PUP Patent expired